Whippany-based Bayer is suing New Brunswick-headquartered Johnson & Johnson over claims the rival pharmaceutical company falsely advertised a competing prostate cancer drug. In a complaint filed Feb.
Bayer filed a lawsuit against Johnson & Johnson and its Janssen Biotech unit, alleging that marketing claims regarding the superiority of J&J's Erleada prostate-cancer drug versus Bayer's Nubeqa are ...
The 120 metres high Bayer Cross, logo of German pharmaceutical and chemical maker Bayer AG, consisting of 1710 LED glass bulbs is seen outside the industrial park "Chempark" of the chemical industry ...
Bayer HealthCare sued Johnson & Johnson and Janssen Biotech for false advertising and unfair competition on Feb. 23 in New York Southern District Court. The suit, brought by Simpson Thacher & Bartlett ...
A month after teaming with former NFL quarterback Tony Romo to market its prostate cancer drug Nubeqa, Bayer has sued Johnson & Johnson (J&J’s) for false advertising of that firm’s rival drug Erleada.
Bayer filed a lawsuit against Johnson & Johnson and its Janssen Biotech unit, alleging that marketing claims regarding the superiority of J&J's Erleada prostate-cancer drug versus Bayer's Nubeqa are ...
Bayer filed a lawsuit against Johnson & Johnson and its Janssen Biotech unit, alleging that marketing claims regarding the superiority of J&J's Erleada prostate-cancer drug versus Bayer's Nubeqa are ...